MichaelKingMDMPH, FAAFP

PubMed

• Retrospective fractional dose reduction in Tc-99m cardiac perfusion SPECT/CT patients: A human and model observer study.
  Pretorius, P. H.,Ramon, A. J.,King, M. A.,Konik, A.,Dahlberg, S. T.,Parker, M. W.,Botkin, N. F.,Johnson, K. L.,Yang, Y.,Wernick, M. N.> ;J Nucl Cardiol. 2019 May 12
• Cardiac motion correction for improving perfusion defect detection in cardiac SPECT at standard and reduced doses of activity.
  Song, C.,Yang, Y.,Wernick, M. N.,Pretorius, P. H.,Slomka, P. J.,King, M. A.> ;Phys Med Biol. 2019 Jan 17
• Evaluation of the effect of reducing administered activity on assessment of function in cardiac gated SPECT.
  Juan Ramon, A.,Yang, Y.,Wernick, M. N.,Pretorius, P. H.,Johnson, K. L.,Slomka, P. J.,King, M. A.> ;J Nucl Cardiol. 2018 Nov 09
• Evaluation of different respiratory gating schemes for cardiac SPECT.
  Zhang, D.,Pretorius, P. H.,Ghaly, M.,Zhang, Q.,King, M. A.,Mok, GSP.> ;J Nucl Cardiol. 2018 Aug 09
• Improving perfusion defect detection with respiratory motion correction in cardiac SPECT at standard and reduced doses.
  Song, C.,Yang, Y.,Ramon, A. J.,Wernick, M. N.,Pretorius, P. H.,Johnson, K. L.,Slomka, P. J.,King, M. A.> ;J Nucl Cardiol. 2018 Aug 01
• Regulation of ATP utilization during metastatic cell migration by collagen architecture.
  Zanotelli, M. R.,Goldblatt, Z. E.,Miller, J. P.,Bordeleau, F.,Li, J.,VanderBurgh, J. A.,Lampi, M. C.,King, M. R.,Reinhart-King, C. A.> ;Mol. Biol. Cell. 2017 Nov 10
• 4D non-local means post-filtering for cardiac gated SPECT.
  Song, C.,Yang, Y.,Pretorius, P. H.,King, M. A.> ;Phys Med Biol. 2017 Dec 29
• Two-stage nanoparticle delivery of piperlongumine and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) anti-cancer therapy.
  Sharkey CC, Li J, Roy S, Wu Q, King MR> ;Technology (Singap). 2016-03-01
• Effect of Pseudopod Extensions on Neutrophil Hemodynamic Transport Near a Wall.
  Rocheleau AD, Wang W, King MR> ;Cell Mol Bioeng. 2016-03-01
• Therapeutic Targeting of Circulating Tumor Cells: An Important Problem That Deserves Careful Study.
  Marshall JR, King MR> ;Cell Mol Bioeng. 2015-12-01
• Lamin A/C deficiency reduces circulating tumor cell resistance to fluid shear stress.
  Mitchell, M. J.,Denais, C.,Chan, M. F.,Wang, Z.,Lammerding, J.,King, M. R.> ;Am. J. Physiol., Cell Physiol.. 2015 Oct 09
• Halloysite Nanotube Coatings Suppress Leukocyte Spreading.
  Hughes, A. D.,Marsh, G.,Waugh, R. E.,Foster, D. G.,King, M. R.> ;Langmuir. 2015 Nov 26
• Super natural killer cells that target metastases in the tumor draining lymph nodes.
  Chandrasekaran, S.,Chan, M. F.,Li, J.,King, M. R.> ;Biomaterials. 2015 Nov 20
• Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles.
  Li, J.,Ai, Y.,Wang, L.,Bu, P.,Sharkey, C. C.,Wu, Q.,Wun, B.,Roy, S.,Shen, X.,King, M. R.> ;Biomaterials. 2015 Nov 01
• Surfactant functionalization induces robust, differential adhesion of tumor cells and blood cells to charged nanotube-coated biomaterials under flow.
  Mitchell MJ, Castellanos CA, King MR> ;Biomaterials. 2015-07-01
• Piperlongumine and immune cytokine TRAIL synergize to promote tumor death.
  Li J, Sharkey CC, King MR> ;Sci Rep. 2015-05-18
• Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood.
  Li, J.,Sharkey, C. C.,Huang, D.,King, M. R.> ;Cell Mol Bioeng. 2015 Mar 24
• Immobilized surfactant-nanotube complexes support selectin-mediated capture of viable circulating tumor cells in the absence of capture antibodies.
  Mitchell, M. J.,Castellanos, C. A.,King, M. R.> ;J Biomed Mater Res A. 2015 Mar 13
• A physical sciences network characterization of circulating tumor cell aggregate transport.
  King, M. R.,Phillips, K. G.,Mitrugno, A.,Lee, T. R.,de Guillebon, A. M.,Chandrasekaran, S.,McGuire, M. J.,Carr, R. T.,Baker-Groberg, S. M.,Rigg, R. A.,Kolatkar, A.,Lut...> ;Am. J. Physiol., Cell Physiol.. 2015 Mar 20
• Cooperative effects of matrix stiffness and fluid shear stress on endothelial cell behavior.
  Kohn, J. C.,Zhou, D. W.,Bordeleau, F.,Zhou, A. L.,Mason, B. N.,Mitchell, M. J.,King, M. R.,Reinhart-King, C. A.> ;Biophys. J.. 2015 Feb 05
• Microenvironment of Tumor-Draining Lymph Nodes: Opportunities for Liposome-Based Targeted Therapy.
  Chandrasekaran, S.,King, M. R.> ;Int J Mol Sci. 2014 Nov 08
• Leukocytes as carriers for targeted cancer drug delivery.
  Mitchell, M. J.,King, M. R.> ;Expert Opin Drug Deliv. 2014 Oct 02
• E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis.
  Yasmin-Karim, S.,King, M. R.,Messing, E. M.,Lee, Y. F.> ;Oncotarget. 2014 Oct 11
• 6 citations
  Completing self-assessment modules during residency is associated with better certification exam results.
  Lars E. Peterson, Brenna Blackburn, Michael R King> ;Family Medicine. 2014 Sep 1
• Differential drug responses of circulating tumor cells within patient blood.
  Hughes, A. D.,Marshall, J. R.,Keller, E.,Powderly, J. D.,Greene, B. T.,King, M. R.> ;Cancer Lett.. 2013 Aug 27
• Join now to see all